
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-01 23:17

Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
2023-12-01 07:26

Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
2023-11-27 16:52

A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this
2023-11-22 19:51

Analysis-Big investors say US markets rally could prove short-lived
By Carolina Mandl, Svea Herbst-Bayliss and David Randall NEW YORK The recent rally that has lifted U.S. stocks
2023-11-22 19:25

Lilly to build $2.5 billion diabetes drug plant in Germany
By Klaus Lauer and Ludwig Burger Eli Lilly will build its first plant in Germany for 2.3 billion
2023-11-17 21:45

Lilly extends tender offer to acquire Point Biopharma to Dec 1
Eli Lilly said on Friday it was extending the deadline for its tender offer for Point Biopharma shares
2023-11-17 20:21

Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:54

Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S gained another $14.5 billion of market value after a key study backed the use of
2023-11-13 20:54

One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:17

Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:53

Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:59